Studying The Undead
ZWN Exclusive interview with Yale Psychologist Dr. Maria Perez
By ZWN Field reporter -
Ruth Ellis Haworth

Read Report:

New Hope With Cell Research on Mortosis Inhibitor

ZWN (AP)
Posted: Nov. 20th, 2007

Two scientific groups announced today a landmark discovery which may reprogram human skin cells to act like embryonic stem cells, whose potential to mature into any other kind of cell in the body may ultimately prove key to curing the necro-mortosis virus.

The study and use of stem cells has long been a fire brand of contention between ethical, religious and scientific groups. The Bush administration has squarely sided with the none funding of stem cell research. Such a ban on funding has long confounded researchers and prevented drug companies like Amcalon from further researching it's promising mortosis inhibitor - XL6.

The White House released a written statement today saying President Bush was "very pleased" with the reports.

"By avoiding techniques that destroy life, while vigorously supporting alternative approaches, President Bush is encouraging scientific advancement within ethical boundaries." it continued.

President Bush has twice vetoed bills that would ease restrictions on the use of federal funding for embryonic stem cells research. The research is considered key in understanding and eventually controlling the necro-mortosis advancement.

Studies in Berlin suggest that Antiviral test drugs can interrupt the process by which a virus reproduces at several stages. The inhibitor XL-6, for example, prevents the virus particle from opening after it enters the cell and can inhibit the manufacture of virus proteins. It also stop the virus from exiting the cell.

"This is the beginning of the end of the controversy," researcher James Thomson, of the University of Wisconsin-Madison, told reporters in a conference call. Thomson, the author of one of Tuesday's papers, is the pioneer of stem cell research. He developed the first human embryonic stem-cell line almost a decade ago.

However, much work remains to be done. The cells produced so far are similar to stem cells in many ways, but the method used to induce them actually involves the administering of several viruses to the cell.

It is hoped that a potential vaccine or even a cure for the devastating mortosis virus could eventually be found. The rejuvenation of dead cells could be a first stage of delaying the onset of reanimation.

Amcalon stock rose dramatically on the announcement this week.(nasdaq: AMCN)